Patient privacy focus of Amgen suit

Jan 09, 2008

Two former employees with the California biotech company Amgen Inc. allege the company persuaded sales people to access patient records to boost sales.

The employees allege Amgen officials persuaded them to access patient records and sometimes pose of medical office personnel to influence the prescription of the arthritis and psoriasis drug Enbrel, the Los Angeles Times reported Wednesday.

Federal law prohibits unauthorized access to patient's medical information. Drug companies are also prohibited from marketing off-label uses, though doctors may prescribe drugs for any reason.

A former FDA lawyer said off-label marketing "is if you have a drug for colon cancer that you promote for brain cancer" while another advocate said Amgen violated FDA regulations by persuading patients to seek the Enbrel for milder forms of the diseases it was approved treat.

Copyright 2008 by United Press International

Explore further: German thalidomide maker wins appeal in Spain compensation case (Update)

add to favorites email to friend print save as pdf

Related Stories

FDA recommends lower doses of anemia drugs

Jun 24, 2011

(AP) -- Food and Drug Administration officials say doctors should use lower doses of anemia drugs when treating patients with failing kidneys due to the increased risk of stroke, blood clots and death.

Amgen posts higher 2Q sales, profit to beat views

Jul 27, 2012

(AP) — Amgen Inc.'s second-quarter net income rose 8 percent as the world's largest biotech company benefited from higher sales for its top-selling drugs and a gain from selling its share of an experimental medicine.

The past, present and future of cancer

Mar 18, 2011

Leading cancer researchers reflected on past achievements and prospects for the future of cancer treatment during a special MIT symposium on Wednesday titled “Conquering Cancer through the Convergence of Science and ...

Recommended for you

Schumacher's doctor sees progress after injury

4 hours ago

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

New MCAT shifts focus, will include humanities

Oct 20, 2014

(HealthDay)—The Medical College Admission Test (MCAT) has been revised, and the latest changes, including more humanities such as social sciences, are due to be implemented next April, according to a report ...

User comments : 0